Skip to primary content
Skip to secondary content

Biotech 365

Main menu

  • Biotech 365
  • Companies
  • Healthcare Investors
    • Healthcare LPs
  • Healthcare Investors Matchmaking
  • Free DEMO
  • Services
    • Preclinical Studies Database
    • Scientific Due Diligence
    • CRO & CDMO Database
  • Contact

Tag Archives: AMPK activator

Poxel – diabetes drug development

Posted on by

Poxel is a biopharma company developing innovative drugs for metabolic diseases, in particular Type 2 diabetes.

Poxel – diabetes drug development

poxel

Continue reading →

Posted in Biotech Companies, Biotech Companies France | Tagged AMPK, AMPK activator, antidiabetic, Bruno Montanari, cholesterol, Cliff Bailey, diabetes, diabetes drug development, drug development, Fabrizio Andreelli, Gerd Bode, glimins, GLP-1, GLP-1 receptor, glucagon-like peptide-1, glycemia, hepatic glucose production, Imeglimin, insulin, insulin secretion, Khoso Baluch, Merck Serono, metabolic diseases, mitcohondrial respiration, muscle glucose uptake, Olivier Martinez, Poxel, Poxel - diabetes drug development, Raphaƫl Wisniewski, Richard Kender, tetrahydrotriazine, Thierry Hercend, Thomas Kuhn, triglycerides, Type 2 diabetes

        Services              Healthcare Investors Database              FAQs               CGU               Biotech & Pharma News             Contact
Proudly powered by WordPress